{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:52:25Z","timestamp":1789455145057,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.jviromet.2007.06.012","type":"journal-article","created":{"date-parts":[[2007,7,27]],"date-time":"2007-07-27T14:30:02Z","timestamp":1185546602000},"page":"136-146","source":"Crossref","is-referenced-by-count":56,"title":["Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations"],"prefix":"10.1016","volume":"146","author":[{"given":"Roger","family":"Paredes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent C.","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Kuritzkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2007.06.012_bib1","doi-asserted-by":"crossref","first-page":"F83","DOI":"10.1097\/00002030-200006160-00001","article-title":"A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study team for the Terry Beirn community programs for clinical research on AIDS","volume":"14","author":"Baxter","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2007.06.012_bib2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jviromet.2005.03.007","article-title":"Discrimination of lamivudine resistant minor HIV-1 variants by selective real-time PCR","volume":"127","author":"Bergroth","year":"2005","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2007.06.012_bib3","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/00002030-199211000-00003","article-title":"HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment","volume":"6","author":"Boucher","year":"1992","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2007.06.012_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/135965350400900420","article-title":"Clinically validated genotype analysis: guiding principles and statistical concerns","volume":"9","author":"Brun-Vezinet","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2007.06.012_bib5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1086\/430709","article-title":"Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection","volume":"41","author":"Campbell","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2007.06.012_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00002030-200202150-00008","article-title":"Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)","volume":"16","author":"Cingolani","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2007.06.012_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1126\/science.7824947","article-title":"HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy","volume":"267","author":"Coffin","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2007.06.012_bib8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00002030-200203080-00009","article-title":"A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy","volume":"16","author":"Cohen","year":"2002","journal-title":"AIDS"},{"issue":"Suppl. 2","key":"10.1016\/j.jviromet.2007.06.012_bib9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1386-6532(05)00393-8","article-title":"Genetic diversity and evolution of hepatitis C virus in the Latin American region","volume":"34","author":"Cristina","year":"2005","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2007.06.012_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/135965359800300302","article-title":"Management of antiretroviral therapy for HIV infection: modelling when to change therapy","volume":"3","author":"D\u2019Amato","year":"1998","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2007.06.012_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.micro.51.1.151","article-title":"RNA virus mutations and fitness for survival","volume":"51","author":"Domingo","year":"1997","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.jviromet.2007.06.012_bib12","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(98)12291-2","article-title":"Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial","volume":"353","author":"Durant","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2007.06.012_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1086\/430742","article-title":"Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012","volume":"192","author":"Flys","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2007.06.012_bib14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.meegid.2005.05.001","article-title":"Invariant aphthovirus consensus nucleotide sequence in the transition to error catastrophe","volume":"5","author":"Gonzalez-Lopez","year":"2005","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.jviromet.2007.06.012_bib15","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/JCM.41.4.1586-1593.2003","article-title":"Accuracy of the TRUGENE HIV-1 genotyping kit","volume":"41","author":"Grant","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2007.06.012_bib16","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1128\/JCM.00449-06","article-title":"Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency","volume":"44","author":"Halvas","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2007.06.012_bib17","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1097\/00002030-199910010-00008","article-title":"Baseline HIV drug resistance profile predicts response to ritonavir\u2013saquinavir protease inhibitor therapy in a community setting","volume":"13","author":"Harrigan","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2007.06.012_bib18","first-page":"295","article-title":"A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575","volume":"19","author":"Haubrich","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2007.06.012_bib19","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/infdis\/171.5.1172","volume":"171","author":"Japour","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2007.06.012_bib20","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1099\/vir.0.81015-0","article-title":"Genetic variation in West Nile virus from naturally infected mosquitoes and birds suggests quasispecies structure and strong purifying selection","volume":"86","author":"Jerzak","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2007.06.012_bib21","first-page":"51","article-title":"Update of the drug resistance mutations in HIV-1: 2005","volume":"13","author":"Johnson","year":"2005","journal-title":"Top. HIV Med."},{"key":"10.1016\/j.jviromet.2007.06.012_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00002030-199102000-00002","article-title":"Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes","volume":"5","author":"Larder","year":"1991","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2007.06.012_bib23","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1002\/elps.200305646","article-title":"A massively parallel PicoTiterPlate-based platform for discrete picoliter-scale polymerase chain reactions","volume":"24","author":"Leamon","year":"2003","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jviromet.2007.06.012_bib24","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/01.aids.0000222071.60620.1d","article-title":"Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission","volume":"20","author":"Loubser","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2007.06.012_bib25","series-title":"Proceedings of the 13th Conference on Retroviruses and Opportunistic Infections","article-title":"In vivo fitness of enfuvirtide-resistant HIV-1 estimated by allele-specific PCR during partial treatment interruption and pulse intensification","author":"Marconi","year":"2006"},{"key":"10.1016\/j.jviromet.2007.06.012_bib26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature03959","article-title":"Genome sequencing in microfabricated high-density picolitre reactors","volume":"437","author":"Margulies","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2007.06.012_bib27","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/379215","article-title":"Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions","volume":"188","author":"Metzner","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2007.06.012_bib28","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1097\/01.aids.0000189878.97480.ed","article-title":"Detection of minor populations of drug-resistant HIV-1 in acute seroconverters","volume":"19","author":"Metzner","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2007.06.012_bib29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00002030-200203290-00008","article-title":"Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial","volume":"16","author":"Meynard","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2007.06.012_bib30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1310\/YHGE-07Y8-T3XF-F6VT","article-title":"Baseline antiretroviral drug susceptibility influences treatment response in patients receiving saquinavir-enhancing therapy","volume":"2","author":"Middleton","year":"2001","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.jviromet.2007.06.012_bib31","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1093\/nar\/17.7.2503","article-title":"Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)","volume":"17","author":"Newton","year":"1989","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jviromet.2007.06.012_bib32","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1128\/JCM.43.11.5696-5704.2005","article-title":"Sensitive phenotypic detection of minor drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants","volume":"43","author":"Nissley","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2007.06.012_bib33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/JCM.43.1.406-413.2005","article-title":"Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis","volume":"43","author":"Palmer","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2007.06.012_bib34","series-title":"Proceedings of the 13th Conference on Retroviruses and Opportunistic Infections","article-title":"Optimization of Allele-specific PCR for Drug-resistant HIV variants using patient-specific consensus sequences for primer design","author":"Palmer","year":"2006"},{"key":"10.1016\/j.jviromet.2007.06.012_bib35","series-title":"Proceedings of the 13th Conference on Retroviruses and Opportunistic Infections","article-title":"Prolonged persistence of M184V mutation and phenotypic resistance to lamivudine in adults with multidrug-resistant HIV-1 infection interrupting treatment with reverse transcriptase inhibitors","author":"Paredes","year":"2006"},{"key":"10.1016\/j.jviromet.2007.06.012_bib36","first-page":"1235","article-title":"Use of coefficient of variation in assessing variability of quantitative assays","volume":"9","author":"Reed","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jviromet.2007.06.012_bib37","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1089\/088922201753197042","article-title":"Impact of HIV type 1 drug resistance mutations and phenotypic resistance profile on virologic response to salvage therapy","volume":"17","author":"Ross","year":"2001","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jviromet.2007.06.012_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nmeth713","article-title":"LigAmp for sensitive detection of single-nucleotide differences","volume":"1","author":"Shi","year":"2004","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jviromet.2007.06.012_bib39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00002030-200201250-00010","article-title":"Clinical utility of HIV-1 genotyping and expert advice: the Havana trial","volume":"16","author":"Tural","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2007.06.012_bib40","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/432916","article-title":"Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management","volume":"192","author":"Wensing","year":"2005","journal-title":"J. Infect. Dis."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093407002418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093407002418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T15:54:36Z","timestamp":1683993276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093407002418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0166093407002418"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2007.06.012","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}